Sonoma Pharmaceuticals (SNOA) Net Margin (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Net Margin of 10.45% for Q1 2026, up 1022.0% year-over-year from 0.93% in Q1 2025, and up 44.52% quarter-over-quarter from 18.83% in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Net Margin (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Net Margin history runs 17 years deep, the most recent figure standing at 10.45% for Q1 2026.
- In Q1 2026, Net Margin rose 1022.0% year-over-year to 10.45%; the TTM figure through Mar 2026 stood at 16.26% (up 794.0% YoY), while the FY2026 annual figure was 16.26%, up 794.0% from the prior year.
- Net Margin for Q1 2026 stood at 10.45%, up from 18.83% in the prior quarter.
- The five-year high for Net Margin was 9.53% in Q3 2025, with the low at 65.86% in Q4 2022.
- The 5-year median for Net Margin is 29.06% (2023), against an average of 30.22%.
- The sharpest annual moves came in 2022 and 2023: Net Margin sank 2786 bps in 2022, then jumped 3827 bps in 2023.
- Sonoma Pharmaceuticals' Net Margin stood at 65.86% in 2022, then jumped by 58 bps to 27.6% in 2023, then advanced by 6 bps to 26.04% in 2024, then increased by 28 bps to 18.83% in 2025, then surged by 45 bps to 10.45% in 2026.
- Business Quant data shows SNOA's Net Margin at 10.45% in Q1 2026, 18.83% in Q4 2025, and 9.53% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | -5.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.15% |
| Mar 31, 2026 | -10.45% |
| Dec 31, 2025 | -18.83% |
| Sep 30, 2025 | -9.53% |
| Jun 30, 2025 | -30.91% |
| Mar 31, 2025 | -20.67% |
| Dec 31, 2024 | -26.04% |
| Sep 30, 2024 | -17.04% |
| Jun 30, 2024 | -33.71% |
| Mar 31, 2024 | -31.03% |
| Dec 31, 2023 | -27.60% |
| Sep 30, 2023 | -54.34% |
| Jun 30, 2023 | -41.38% |
| Mar 31, 2023 | -43.40% |
| Dec 31, 2022 | -65.86% |
| Sep 30, 2022 | -30.53% |
| Jun 30, 2022 | -22.27% |
| Sep 30, 2021 | -2.67% |
| Jun 30, 2021 | -29.80% |
| Mar 31, 2021 | -10.57% |